{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:10:58Z","timestamp":1793459458764,"version":"4.5.0"},"reference-count":137,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2014,6,9]],"date-time":"2014-06-09T00:00:00Z","timestamp":1402272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The mucosal surface is the largest route through which pathogens enter the human body. To control the outbreak of mucosal infectious diseases, we must use our knowledge of the mucosal immune system to create vaccines that elicit protective mucosal and systemic immunity. Mucosal vaccines have advantages over traditional injectable vaccines in that they not only induce effective mucosal immune responses, but they also do not cause physical or psychological discomfort. Mucosal vaccines currently licensed for human use include oral vaccines against Vibrio cholerae, Salmonella typhi, poliovirus and rotavirus, and nasal vaccines against influenza virus. To further improve the existing vaccines, it will be necessary to develop novel vaccine production, storage and delivery systems through innovative strategies derived from interdisciplinary scientific research. Our accumulated knowledge of the innate and acquired arms of the mucosal immune system and the recent scientific and technical advancements in the fields of molecular biology, plant biology, bio-engineering and chemical engineering, genome biology and systems biology have created a unique research and development platform for the development of the next generation of mucosal vaccines. This review summarizes the current perspectives and future directions of mucosal vaccine development with emphasis on oral and nasal vaccines for the control of infectious diseases.<\/jats:p>","DOI":"10.1093\/intimm\/dxu063","type":"journal-article","created":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T05:21:05Z","timestamp":1402377665000},"page":"517-528","source":"Crossref","is-referenced-by-count":120,"title":["Challenges in mucosal vaccines for the control of infectious diseases"],"prefix":"10.1093","volume":"26","author":[{"given":"Tatsuhiko","family":"Azegami","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, Division of Mucosal Immunology, International Research and Development Center for Mucosal Vaccines, Institute of Medical Science, University of Tokyo 1 , Tokyo 108-8639 , Japan"},{"name":"Department of Internal Medicine, School of Medicine, Keio University 2 , Tokyo 160-8582 , Japan"},{"name":"3 Present address: 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan"},{"name":"4 Present address: 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Yuki","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Division of Mucosal Immunology, International Research and Development Center for Mucosal Vaccines, Institute of Medical Science, University of Tokyo 1 , Tokyo 108-8639 , Japan"},{"name":"3 Present address: 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kiyono","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Division of Mucosal Immunology, International Research and Development Center for Mucosal Vaccines, Institute of Medical Science, University of Tokyo 1 , Tokyo 108-8639 , Japan"},{"name":"3 Present address: 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,6,9]]},"reference":[{"key":"2022072022285805100_CIT0001","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fimmu.2011.00021","article-title":"Edward jenner and the small pox vaccine","volume":"2","author":"Smith","year":"2011","journal-title":"Front. Immunol"},{"key":"2022072022285805100_CIT0002","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMra1204186","article-title":"Designing tomorrow\u2019s vaccines","volume":"368","author":"Nabel","year":"2013","journal-title":"N. Engl. J. Med"},{"key":"2022072022285805100_CIT0003","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000059397","article-title":"Mucosal immunity: its role in defense and allergy","volume":"128","author":"Tlaskalov\u00e1-Hogenov\u00e1","year":"2002","journal-title":"Int. Arch. Allergy Immunol"},{"key":"2022072022285805100_CIT0004","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/S0140-6736(10)60549-1","article-title":"Global, regional, and national causes of child mortality in 2008: a systematic analysis","volume":"375","author":"Black","year":"2010","journal-title":"Lancet"},{"key":"2022072022285805100_CIT0005","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1128\/IAI.73.7.4088-4097.2005","article-title":"Nontoxic Shiga toxin derivatives from Escherichia coli possess adjuvant activity for the augmentation of antigen-specific immune responses via dendritic cell activation","volume":"73","author":"Ohmura","year":"2005","journal-title":"Infect. Immun"},{"key":"2022072022285805100_CIT0006","doi-asserted-by":"crossref","first-page":"10986","DOI":"10.1073\/pnas.0703766104","article-title":"Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination","volume":"104","author":"Nochi","year":"2007","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2022072022285805100_CIT0007","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1586\/erv.09.61","article-title":"Mucosal vaccines: novel advances in technology and delivery","volume":"8","author":"Yuki","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"2022072022285805100_CIT0008","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat. Med"},{"key":"2022072022285805100_CIT0009","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.4049\/jimmunol.152.7.3282","article-title":"Role of alpha 4-integrins in lymphocyte homing to mucosal tissues in vivo","volume":"152","author":"Hamann","year":"1994","journal-title":"J. Immunol"},{"key":"2022072022285805100_CIT0010","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.4049\/jimmunol.162.9.5173","article-title":"Differential homing commitments of antigen-specific T cells after oral or parenteral immunization in humans","volume":"162","author":"Kantele","year":"1999","journal-title":"J. Immunol"},{"key":"2022072022285805100_CIT0011","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1172\/JCI0215988","article-title":"CCL25 mediates the localization of recently activated CD8alphabeta(+) lymphocytes to the small-intestinal mucosa","volume":"110","author":"Svensson","year":"2002","journal-title":"J. Clin. Invest"},{"key":"2022072022285805100_CIT0012","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0092-8674(95)90491-3","article-title":"Alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow","volume":"80","author":"Berlin","year":"1995","journal-title":"Cell"},{"key":"2022072022285805100_CIT0013","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.4049\/jimmunol.173.6.3668","article-title":"CC chemokine ligands 25 and 28 play essential roles in intestinal extravasation of IgA antibody-secreting cells","volume":"173","author":"Hieshima","year":"2004","journal-title":"J. Immunol"},{"key":"2022072022285805100_CIT0014","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1084\/jem.190.9.1241","article-title":"Human G protein-coupled receptor GPR-9-6\/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis","volume":"190","author":"Zabel","year":"1999","journal-title":"J. Exp. Med"},{"key":"2022072022285805100_CIT0015","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature01726","article-title":"Selective imprinting of gut-homing T cells by Peyer\u2019s patch dendritic cells","volume":"424","author":"Mora","year":"2003","journal-title":"Nature"},{"key":"2022072022285805100_CIT0016","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/346425a0","article-title":"Adhesion receptors of the immune system","volume":"346","author":"Springer","year":"1990","journal-title":"Nature"},{"key":"2022072022285805100_CIT0017","doi-asserted-by":"crossref","first-page":"22313","DOI":"10.1074\/jbc.M001461200","article-title":"Identification of a novel chemokine (CCL28), which binds CCR10 (GPR2)","volume":"275","author":"Wang","year":"2000","journal-title":"J. Biol. Chem"},{"key":"2022072022285805100_CIT0018","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2567.2007.02671.x","article-title":"Differential expression of adhesion molecules and chemokines between nasal and small intestinal mucosae: implications for T- and sIgA+ B-lymphocyte recruitment","volume":"122","author":"Bourges","year":"2007","journal-title":"Immunology"},{"key":"2022072022285805100_CIT0019","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.vetmic.2006.04.006","article-title":"Overview of new vaccines and technologies","volume":"117","author":"Chalmers","year":"2006","journal-title":"Vet. Microbiol"},{"key":"2022072022285805100_CIT0020","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1177\/003335490812300412","article-title":"Economic benefits of hepatitis B vaccination at sexually transmitted disease clinics in the U.S","volume":"123","author":"Miriti","year":"2008","journal-title":"Public Health Rep"},{"key":"2022072022285805100_CIT0021","first-page":"789","article-title":"Unsafe injections in the developing world and transmission of bloodborne pathogens: a review","volume":"77","author":"Simonsen","year":"1999","journal-title":"Bull. World Health Organ"},{"key":"2022072022285805100_CIT0022","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1016\/S0140-6736(12)60436-X","article-title":"Cholera","volume":"379","author":"Harris","year":"2012","journal-title":"Lancet"},{"key":"2022072022285805100_CIT0023","first-page":"321","article-title":"Cholera, 2012","volume":"88","author":"WHO","year":"2013","journal-title":"Wkly Epidemiol. Rec"},{"key":"2022072022285805100_CIT0024","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/292413a0","article-title":"Actions of cholera toxin and the prevention and treatment of cholera","volume":"292","author":"Holmgren","year":"1981","journal-title":"Nature"},{"key":"2022072022285805100_CIT0025","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1172\/JCI106599","article-title":"Stimulation of intestinal mucosal adenyl cyclase by cholera enterotoxin and prostaglandins","volume":"50","author":"Kimberg","year":"1971","journal-title":"J. Clin. Invest"},{"key":"2022072022285805100_CIT0026","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/infdis\/124.4.415","article-title":"Deactivation of cholera toxin by ganglioside","volume":"124","author":"Van Heyningen","year":"1971","journal-title":"J. Infect. Dis"},{"key":"2022072022285805100_CIT0027","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1128\/iai.8.2.208-214.1973","article-title":"Tissue receptor for cholera exotoxin: postulated structure from studies with GM1 ganglioside and related glycolipids","volume":"8","author":"Holmgren","year":"1973","journal-title":"Infect. Immun"},{"key":"2022072022285805100_CIT0028","first-page":"229","article-title":"Report of the 1966-67 cholera vaccine trial in rural East Pakistan","volume":"47","author":"Mosley","year":"1972","journal-title":"Bull. World Health Organ"},{"key":"2022072022285805100_CIT0029","first-page":"381","article-title":"Field trials of monovalent Ogawa and Inaba cholera vaccines in rural Bangladesh\u2013three years of observation","volume":"49","author":"Mosley","year":"1973","journal-title":"Bull. World Health Organ"},{"key":"2022072022285805100_CIT0030","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/269602a0","article-title":"Development of improved cholera vaccine based on subunit toxoid","volume":"269","author":"Holmgren","year":"1977","journal-title":"Nature"},{"key":"2022072022285805100_CIT0031","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(86)91944-6","article-title":"Field trial of oral cholera vaccines in Bangladesh","volume":"2","author":"Clemens","year":"1986","journal-title":"Lancet"},{"key":"2022072022285805100_CIT0032","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0140-6736(90)90080-O","article-title":"Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up","volume":"335","author":"Clemens","year":"1990","journal-title":"Lancet"},{"key":"2022072022285805100_CIT0033","doi-asserted-by":"crossref","first-page":"e1844","DOI":"10.1371\/journal.pntd.0001844","article-title":"Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar","volume":"6","author":"Schaetti","year":"2012","journal-title":"PLoS Negl. Trop. Dis"},{"key":"2022072022285805100_CIT0034","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1016\/j.vaccine.2010.05.008","article-title":"Cholera vaccines: WHO position paper-Recommendations","volume":"28","year":"2010","journal-title":"Vaccine"},{"key":"2022072022285805100_CIT0035","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/S0140-6736(09)61297-6","article-title":"Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial","volume":"374","author":"Sur","year":"2009","journal-title":"Lancet"},{"key":"2022072022285805100_CIT0036","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1524-4733.2009.00562.x","article-title":"Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis","volume":"12","author":"Jeuland","year":"2009","journal-title":"Value Health"},{"key":"2022072022285805100_CIT0037","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/cid\/cir141","article-title":"Oral vaccines against cholera","volume":"52","author":"Shin","year":"2011","journal-title":"Clin. Infect. Dis"},{"key":"2022072022285805100_CIT0038","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJMra020201","article-title":"Typhoid fever","volume":"347","author":"Parry","year":"2002","journal-title":"N. Engl. J. Med"},{"key":"2022072022285805100_CIT0039","first-page":"346","article-title":"The global burden of typhoid fever","volume":"82","author":"Crump","year":"2004","journal-title":"Bull. World Health Organ"},{"key":"2022072022285805100_CIT0040","first-page":"903","article-title":"A controlled field trial to evaluate the protective capacity of a single dose of acetone-killed agar-grown and heat-killed broth-grown typhoid vaccines","volume":"40","author":"Hejfec","year":"1969","journal-title":"Bull. World Health Organ"},{"key":"2022072022285805100_CIT0041","first-page":"623","article-title":"A controlled field trial of the effectiveness of acetone-dried and inactivated and heat-phenol-inactivated typhoid vaccines in Yugoslavia","volume":"30","author":"Stuhl","year":"1964","journal-title":"Bull. World Health Organ"},{"key":"2022072022285805100_CIT0042","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1128\/iai.2.3.309-315.1970","article-title":"Immunity in experimental Salmonellosis I. Protection induced by rough mutants of Salmonella typhimurium","volume":"2","author":"Germanier","year":"1970","journal-title":"Infect. Immun"},{"key":"2022072022285805100_CIT0043","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/infdis\/131.5.553","article-title":"Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine","volume":"131","author":"Germanier","year":"1975","journal-title":"J. Infect. Dis"},{"key":"2022072022285805100_CIT0044","first-page":"CD001261","article-title":"Vaccines for preventing typhoid fever","volume":"1","author":"Anwar","year":"2014","journal-title":"Cochrane Database Syst. Rev"},{"key":"2022072022285805100_CIT0045","doi-asserted-by":"crossref","first-page":"e5879","DOI":"10.1371\/journal.pone.0005879","article-title":"Priming of Salmonella enterica serovar typhi-specific CD8(+) T cells by suicide dendritic cell cross-presentation in humans","volume":"4","author":"Salerno-Goncalves","year":"2009","journal-title":"PLoS One"},{"key":"2022072022285805100_CIT0046","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nm1743","article-title":"Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut","volume":"14","author":"Raffatellu","year":"2008","journal-title":"Nat. Med"},{"key":"2022072022285805100_CIT0047","doi-asserted-by":"crossref","first-page":"e38408","DOI":"10.1371\/journal.pone.0038408","article-title":"Heterogeneity of multifunctional IL-17A producing S. typhi-specific CD8+ T cells in volunteers following Ty21a typhoid immunization","volume":"7","author":"McArthur","year":"2012","journal-title":"PLoS One"},{"key":"2022072022285805100_CIT0048","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1016\/j.vaccine.2012.07.051","article-title":"Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination","volume":"30","author":"Pakkanen","year":"2012","journal-title":"Vaccine"},{"key":"2022072022285805100_CIT0049","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0140-6736(03)14854-4","article-title":"Influenza","volume":"362","author":"Nicholson","year":"2003","journal-title":"Lancet"},{"key":"2022072022285805100_CIT0050","first-page":"461","article-title":"Vaccines against influenza WHO position paper - November 2012","volume":"87","author":"WHO","year":"2012","journal-title":"Wkly Epidemiol. Rec"},{"key":"2022072022285805100_CIT0051","author":"FDA"},{"key":"2022072022285805100_CIT0052","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/infdis\/jir436","article-title":"Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children","volume":"204","author":"Hoft","year":"2011","journal-title":"J. Infect. Dis"},{"key":"2022072022285805100_CIT0053","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1086\/605413","article-title":"Phosphoantigen-expanded human gammadelta T cells display potent cytotoxicity against monocyte-derived macrophages infected with human and avian influenza viruses","volume":"200","author":"Qin","year":"2009","journal-title":"J. Infect. Dis"},{"key":"2022072022285805100_CIT0054","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1056\/NEJMoa0808652","article-title":"Comparative efficacy of inactivated and live attenuated influenza vaccines","volume":"361","author":"Monto","year":"2009","journal-title":"N. Engl. J. Med"},{"key":"2022072022285805100_CIT0055","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jama.282.2.137","article-title":"Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial","volume":"282","author":"Nichol","year":"1999","journal-title":"J. Am. Med. Assoc"},{"key":"2022072022285805100_CIT0056","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1128\/CVI.00544-13","article-title":"Genetic and antigenic typing of seasonal influenza virus breakthrough cases from a 2008-2009 vaccine efficacy trial","volume":"21","author":"Durviaux","year":"2014","journal-title":"Clin. Vaccine Immunol"},{"key":"2022072022285805100_CIT0057","doi-asserted-by":"crossref","first-page":"e74064","DOI":"10.1371\/journal.pone.0074064","article-title":"Virological surveillance of influenza viruses during the 2008-09, 2009-10 and 2010-11 seasons in Tunisia","volume":"8","author":"El Moussi","year":"2013","journal-title":"PLoS One"},{"key":"2022072022285805100_CIT0058","doi-asserted-by":"crossref","first-page":"9391","DOI":"10.1016\/j.vaccine.2011.09.109","article-title":"A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults","volume":"29","author":"Block","year":"2011","journal-title":"Vaccine"},{"key":"2022072022285805100_CIT0059","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/INF.0b013e31825687b0","article-title":"Immunogenicity and safety of a quadrivalent live attenuated influenza vaccine in children","volume":"31","author":"Block","year":"2012","journal-title":"Pediatr. Infect. Dis. J"},{"key":"2022072022285805100_CIT0060","first-page":"73","article-title":"Polio vaccines: WHO position paper, January 2014","volume":"89","author":"WHO","year":"2014","journal-title":"Wkly Epidemiol. Rec"},{"key":"2022072022285805100_CIT0061","first-page":"80","article-title":"Worldwide status of poliomyelitis in 1986, 1987 and 1988, and plans for its global eradication by the year 2000","volume":"43","author":"Robertson","year":"1990","journal-title":"World Health Stat. Q"},{"key":"2022072022285805100_CIT0062","first-page":"528","article-title":"Performance of acute flaccid paralysis (AFP) surveillance and incidence of poliomyelitis, 2013","volume":"88","author":"WHO","year":"2013","journal-title":"Wkly Epidemiol. Rec"},{"key":"2022072022285805100_CIT0063","first-page":"234","article-title":"Differentiation of types of poliomyelitis viruses; the grouping of 14 strains into three basic immunological types","volume":"49","author":"Bodian","year":"1949","journal-title":"Am. J. Hyg"},{"key":"2022072022285805100_CIT0064","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1586\/erv.11.106","article-title":"Mucosal immunity to poliovirus","volume":"10","author":"Ogra","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"2022072022285805100_CIT0065","first-page":"51","article-title":"Recommendations to assure the quality, safety and efficacy of poliomyelitis vaccines (oral, live, attenuated)","volume":"980","author":"WHO","year":"2012","journal-title":"World Health Organ Tech Rep Ser"},{"key":"2022072022285805100_CIT0066","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJM196810242791701","article-title":"Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection","volume":"279","author":"Ogra","year":"1968","journal-title":"N. Engl. J. Med"},{"key":"2022072022285805100_CIT0067","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.yexmp.2008.08.001","article-title":"Oral polio vaccination leads to oligoclonal expansion of TCRBV16+ and TCRBV13+ T cells in the colon of rhesus macaques","volume":"85","author":"H\u00f6rer","year":"2008","journal-title":"Exp. Mol. Pathol"},{"key":"2022072022285805100_CIT0068","first-page":"358","article-title":"Update on vaccine-derived polioviruses detected worldwide, April 2011-June 2012","volume":"87","author":"WHO","year":"2012","journal-title":"Wkly Epidemiol. Rec"},{"key":"2022072022285805100_CIT0069","first-page":"49","article-title":"Rotavirus vaccines. WHO position paper - January 2013","volume":"88","author":"WHO","year":"2013","journal-title":"Wkly Epidemiol. Rec"},{"key":"2022072022285805100_CIT0070","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/rmv.448","article-title":"Global distribution of rotavirus serotypes\/genotypes and its implication for the development and implementation of an effective rotavirus vaccine","volume":"15","author":"Santos","year":"2005","journal-title":"Rev. Med. Virol"},{"key":"2022072022285805100_CIT0071","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(83)90734-1","article-title":"Immunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young children","volume":"2","author":"Vesikari","year":"1983","journal-title":"Lancet"},{"key":"2022072022285805100_CIT0072","first-page":"350","article-title":"Immune response of infants and children to low-passage bovine rotavirus (strain WC3)","volume":"140","author":"Clark","year":"1986","journal-title":"Am. J. Dis. Child"},{"key":"2022072022285805100_CIT0073","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00006454-198601000-00005","article-title":"Safety, infectivity, transmissibility and immunogenicity of rhesus rotavirus vaccine (MMU 18006) in infants","volume":"5","author":"Losonsky","year":"1986","journal-title":"Pediatr. Infect. Dis"},{"key":"2022072022285805100_CIT0074","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0140-6736(86)91643-0","article-title":"Failure of live, attenuated oral rotavirus vaccine","volume":"2","author":"De Mol","year":"1986","journal-title":"Lancet"},{"key":"2022072022285805100_CIT0075","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(87)90649-0","article-title":"Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants","volume":"1","author":"Hanlon","year":"1987","journal-title":"Lancet"},{"key":"2022072022285805100_CIT0076","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0923-2516(91)90008-Q","article-title":"Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa","volume":"142","author":"Georges-Courbot","year":"1991","journal-title":"Res. Virol"},{"key":"2022072022285805100_CIT0077","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1128\/CMR.9.3.423","article-title":"Rotavirus vaccines: an overview","volume":"9","author":"Midthun","year":"1996","journal-title":"Clin. Microbiol. Rev"},{"issue":"RR-2","key":"2022072022285805100_CIT0078","first-page":"1","article-title":"Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children: recommendation of the Advisory Committee on Immunization Practices (ACIP)","volume":"48","author":"CDC","year":"1999","journal-title":"MMWR Morb. Mortal. Wkly Rep"},{"key":"2022072022285805100_CIT0079","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0140-6736(97)05118-0","article-title":"Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis","volume":"350","author":"Joensuu","year":"1997","journal-title":"Lancet"},{"key":"2022072022285805100_CIT0080","first-page":"577","article-title":"Intussusception among recipients of rotavirus vaccine -United States, 1998\u20131999","volume":"48","author":"CDC","year":"1999","journal-title":"MMWR Morb. Mortal. Wkly Rep"},{"key":"2022072022285805100_CIT0081","doi-asserted-by":"crossref","first-page":"e827","DOI":"10.1542\/peds.2005-1556","article-title":"Intussusception after administration of the rhesus tetravalent rotavirus vaccine (Rotashield): the search for a pathogenic mechanism","volume":"117","author":"Lynch","year":"2006","journal-title":"Pediatrics"},{"key":"2022072022285805100_CIT0082","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0140-6736(10)60755-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial","volume":"376","author":"Zaman","year":"2010","journal-title":"Lancet"},{"key":"2022072022285805100_CIT0083","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0140-6736(10)60889-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial","volume":"376","author":"Armah","year":"2010","journal-title":"Lancet"},{"key":"2022072022285805100_CIT0084","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(07)61744-9","article-title":"Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study","volume":"370","author":"Vesikari","year":"2007","journal-title":"Lancet"},{"key":"2022072022285805100_CIT0085","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0140-6736(08)60524-3","article-title":"Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study","volume":"371","author":"Linhares","year":"2008","journal-title":"Lancet"},{"key":"2022072022285805100_CIT0086","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1017\/S1462399408000574","article-title":"Rotavirus vaccines: how they work or don\u2019t work","volume":"10","author":"Ward","year":"2008","journal-title":"Expert Rev. Mol. Med"},{"key":"2022072022285805100_CIT0087","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1303164","article-title":"Intussusception risk after rotavirus vaccination in U.S. infants","volume":"370","author":"Yih","year":"2014","journal-title":"N. Engl. J. Med"},{"key":"2022072022285805100_CIT0088","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa1311738","article-title":"Risk of intussusception after monovalent rotavirus vaccination","volume":"370","author":"Weintraub","year":"2014","journal-title":"N. Engl. J. Med"},{"key":"2022072022285805100_CIT0089","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMe1315836","article-title":"Rotavirus vaccines\u2013balancing intussusception risks and health benefits","volume":"370","author":"Glass","year":"2014","journal-title":"N. Engl. J. Med"},{"key":"2022072022285805100_CIT0090","doi-asserted-by":"crossref","first-page":"e87411","DOI":"10.1371\/journal.pone.0087411","article-title":"A low gastric pH mouse model to evaluate live attenuated bacterial vaccines","volume":"9","author":"Brenneman","year":"2014","journal-title":"PLoS One"},{"key":"2022072022285805100_CIT0091","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nmat2784","article-title":"Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines","volume":"9","author":"Nochi","year":"2010","journal-title":"Nat. Mater"},{"key":"2022072022285805100_CIT0092","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/10611860903067301","article-title":"Oral delivery of gastro-resistant microencapsulated typhoid vaccine","volume":"17","author":"Uddin","year":"2009","journal-title":"J. Drug Target"},{"key":"2022072022285805100_CIT0093","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1248\/bpb.29.1223","article-title":"Preparation of double liposomes and their efficiency as an oral vaccine carrier","volume":"29","author":"Ogue","year":"2006","journal-title":"Biol. Pharm. Bull"},{"key":"2022072022285805100_CIT0094","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1084\/jem.20070607","article-title":"A novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses","volume":"204","author":"Nochi","year":"2007","journal-title":"J. Exp. Med"},{"key":"2022072022285805100_CIT0095","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/intimm\/dxs094","article-title":"Regulation of intestinal homeostasis by innate and adaptive immunity","volume":"24","author":"Kayama","year":"2012","journal-title":"Int. Immunol"},{"key":"2022072022285805100_CIT0096","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1126\/science.1188510","article-title":"Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine","volume":"329","author":"Manicassamy","year":"2010","journal-title":"Science"},{"key":"2022072022285805100_CIT0097","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1002\/1529-0131(200109)44:9<1993::AID-ART347>3.0.CO;2-A","article-title":"Control of rheumatoid arthritis by oral tolerance","volume":"44","author":"Choy","year":"2001","journal-title":"Arthritis Rheum"},{"key":"2022072022285805100_CIT0098","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.4049\/jimmunol.179.9.5633","article-title":"Perspectives on mucosal vaccines: is mucosal tolerance a barrier?","volume":"179","author":"Mestecky","year":"2007","journal-title":"J. Immunol"},{"key":"2022072022285805100_CIT0099","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1053\/j.gastro.2004.03.076","article-title":"Failure to induce oral tolerance to a soluble protein in patients with inflammatory bowel disease","volume":"126","author":"Kraus","year":"2004","journal-title":"Gastroenterology"},{"key":"2022072022285805100_CIT0100","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1002\/eji.200324154","article-title":"The B subunit of Escherichia coli heat labile enterotoxin abrogates oral tolerance, promoting predominantly Th2-type immune responses","volume":"33","author":"Plant","year":"2003","journal-title":"Eur. J. Immunol"},{"key":"2022072022285805100_CIT0101","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/bit.1095","article-title":"Production of a recombinant hybrid molecule of cholera toxin-B-subunit and proteolipid-protein-peptide for the treatment of experimental encephalomyelitis","volume":"74","author":"Yuki","year":"2001","journal-title":"Biotechnol. Bioeng"},{"key":"2022072022285805100_CIT0102","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/infdis\/173.3.627","article-title":"Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin","volume":"173","author":"Takahashi","year":"1996","journal-title":"J. Infect. Dis"},{"key":"2022072022285805100_CIT0103","doi-asserted-by":"crossref","first-page":"25ra24","DOI":"10.1126\/scitranslmed.3000759","article-title":"Plasmacytoid dendritic cells delineate immunogenicity of influenza vaccine subtypes","volume":"2","author":"Koyama","year":"2010","journal-title":"Sci. Transl. Med"},{"key":"2022072022285805100_CIT0104","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/infdis\/172.4.1126","article-title":"Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1","volume":"172","author":"Kenner","year":"1995","journal-title":"J. Infect. Dis"},{"key":"2022072022285805100_CIT0105","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1586\/erv.09.137","article-title":"Development of Peru-15 (CholeraGarde), a live-attenuated oral cholera vaccine: 1991-2009","volume":"8","author":"Chowdhury","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"2022072022285805100_CIT0106","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.vaccine.2006.08.031","article-title":"Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants","volume":"25","author":"Qadri","year":"2007","journal-title":"Vaccine"},{"key":"2022072022285805100_CIT0107","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1086\/518135","article-title":"CVD 908, CVD 908-htrA, and CVD 909 live oral typhoid vaccines: a logical progression","volume":"45","author":"Tacket","year":"2007","journal-title":"Clin. Infect. Dis"},{"key":"2022072022285805100_CIT0108","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1172\/JCI115876","article-title":"Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine","volume":"90","author":"Hone","year":"1992","journal-title":"J. Clin. Invest"},{"key":"2022072022285805100_CIT0109","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1128\/IAI.68.3.1196-1201.2000","article-title":"Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers","volume":"68","author":"Tacket","year":"2000","journal-title":"Infect. Immun"},{"key":"2022072022285805100_CIT0110","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1086\/421469","article-title":"Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide","volume":"190","author":"Tacket","year":"2004","journal-title":"J. Infect. Dis"},{"key":"2022072022285805100_CIT0111","article-title":"Novel transgenic rice-based vaccines","author":"Azegami","year":"2014","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"2022072022285805100_CIT0112","doi-asserted-by":"crossref","first-page":"8794","DOI":"10.1073\/pnas.0914121107","article-title":"Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine","volume":"107","author":"Tokuhara","year":"2010","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2022072022285805100_CIT0113","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.4049\/jimmunol.0901480","article-title":"A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity","volume":"183","author":"Nochi","year":"2009","journal-title":"J. Immunol"},{"key":"2022072022285805100_CIT0114","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.4161\/hv.25458","article-title":"Intranasal vaccination with an inactivated whole influenza virus vaccine induces strong antibody responses in serum and nasal mucus of healthy adults","volume":"9","author":"Ainai","year":"2013","journal-title":"Hum. Vaccin. Immunother"},{"key":"2022072022285805100_CIT0115","first-page":"77","article-title":"Neuraminidase antibodies in serum and nasal washings after immunization by means of live and killed whole virion, split virion and subunit (HA and N) influenza vaccines","volume":"39","author":"Kuwert","year":"1977","journal-title":"Dev. Biol. Stand"},{"key":"2022072022285805100_CIT0116","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJM197703102961012","article-title":"Influenza vaccine: split-product versus whole-virus types\u2013How do they differ","volume":"296","author":"Gross","year":"1977","journal-title":"N. Engl. J. Med"},{"key":"2022072022285805100_CIT0117","doi-asserted-by":"crossref","first-page":"6276","DOI":"10.1016\/j.vaccine.2009.04.074","article-title":"PolyI: polyC12U adjuvant-combined intranasal vaccine protects mice against highly pathogenic H5N1 influenza virus variants","volume":"27","author":"Ichinohe","year":"2009","journal-title":"Vaccine"},{"key":"2022072022285805100_CIT0118","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1016\/j.vaccine.2009.01.071","article-title":"Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer","volume":"27","author":"Jasani","year":"2009","journal-title":"Vaccine"},{"key":"2022072022285805100_CIT0119","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.1016\/j.vaccine.2013.10.061","article-title":"Phase I\/II trial of a replication-deficient trivalent influenza virus vaccine lacking NS1","volume":"31","author":"M\u00f6ssler","year":"2013","journal-title":"Vaccine"},{"key":"2022072022285805100_CIT0120","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJMra1200894","article-title":"Tuberculosis","volume":"368","author":"Zumla","year":"2013","journal-title":"N. Engl. J. Med"},{"key":"2022072022285805100_CIT0121","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"J. Am. Med. Assoc"},{"key":"2022072022285805100_CIT0122","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jinf.2012.03.012","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) complications associated with primary immunodeficiency diseases","volume":"64","author":"Norouzi","year":"2012","journal-title":"J. Infect"},{"key":"2022072022285805100_CIT0123","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet"},{"key":"2022072022285805100_CIT0124","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.vaccine.2013.11.108","article-title":"Recombinant Ag85B vaccine by taking advantage of characteristics of human parainfluenza type 2 virus vector showed Mycobacteria-specific immune responses by intranasal immunization","volume":"32","author":"Watanabe","year":"2014","journal-title":"Vaccine"},{"key":"2022072022285805100_CIT0125","doi-asserted-by":"crossref","first-page":"e5856","DOI":"10.1371\/journal.pone.0005856","article-title":"Intranasal mucosal boosting with an adenovirus-vectored vaccine markedly enhances the protection of BCG-primed guinea pigs against pulmonary tuberculosis","volume":"4","author":"Xing","year":"2009","journal-title":"PLoS One"},{"key":"2022072022285805100_CIT0126","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1073\/pnas.0708684105","article-title":"Sublingual vaccination with influenza virus protects mice against lethal viral infection","volume":"105","author":"Song","year":"2008","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2022072022285805100_CIT0127","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.4049\/jimmunol.1202979","article-title":"Intrarectal immunization and IgA antibody-secreting cell homing to the small intestine","volume":"190","author":"Agnello","year":"2013","journal-title":"J. Immunol"},{"key":"2022072022285805100_CIT0128","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.vaccine.2006.11.002","article-title":"Intravaginal administration of an inactivated vaccine prevents lesions induced by caprine herpesvirus-1 in goats","volume":"25","author":"Camero","year":"2007","journal-title":"Vaccine"},{"key":"2022072022285805100_CIT0129","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.4049\/jimmunol.1000680","article-title":"Eye mucosa: an efficient vaccine delivery route for inducing protective immunity","volume":"185","author":"Seo","year":"2010","journal-title":"J. Immunol"},{"key":"2022072022285805100_CIT0130","doi-asserted-by":"crossref","first-page":"e27953","DOI":"10.1371\/journal.pone.0027953","article-title":"Sublingual immunization with M2-based vaccine induces broad protective immunity against influenza","volume":"6","author":"Shim","year":"2011","journal-title":"PLoS One"},{"key":"2022072022285805100_CIT0131","doi-asserted-by":"crossref","first-page":"e39921","DOI":"10.1371\/journal.pone.0039921","article-title":"Sublingual immunization with a live attenuated influenza a virus lacking the nonstructural protein 1 induces broad protective immunity in mice","volume":"7","author":"Park","year":"2012","journal-title":"PLoS One"},{"key":"2022072022285805100_CIT0132","doi-asserted-by":"crossref","first-page":"e33736","DOI":"10.1371\/journal.pone.0033736","article-title":"Systemic and mucosal immune responses to sublingual or intramuscular human papilloma virus antigens in healthy female volunteers","volume":"7","author":"Huo","year":"2012","journal-title":"PLoS One"},{"key":"2022072022285805100_CIT0133","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1016\/j.vaccine.2007.11.002","article-title":"Phase I study of a candidate vaccine based on recombinant HIV-1 gp160 (MN\/LAI) administered by the mucosal route to HIV-seronegative volunteers: the ANRS VAC14 study","volume":"26","author":"Pialoux","year":"2008","journal-title":"Vaccine"},{"key":"2022072022285805100_CIT0134","doi-asserted-by":"crossref","first-page":"e25165","DOI":"10.1371\/journal.pone.0025165","article-title":"Phase I randomised clinical trial of an HIV-1(CN54), clade C, trimeric envelope vaccine candidate delivered vaginally","volume":"6","author":"Lewis","year":"2011","journal-title":"PLoS One"},{"key":"2022072022285805100_CIT0135","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1128\/IAI.66.12.5630-5635.1998","article-title":"Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: evidence for compartmentalization within the common mucosal immune system in humans","volume":"66","author":"Kantele","year":"1998","journal-title":"Infect. Immun"},{"key":"2022072022285805100_CIT0136","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/nm1201-1320","article-title":"Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques","volume":"7","author":"Belyakov","year":"2001","journal-title":"Nat. Med"},{"key":"2022072022285805100_CIT0137","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1084\/jem.20091436","article-title":"Id2-, RORgammat-, and LTbetaR-independent initiation of lymphoid organogenesis in ocular immunity","volume":"206","author":"Nagatake","year":"2009","journal-title":"J. Exp. Med"}],"container-title":["International Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/intimm\/article-pdf\/26\/9\/517\/45033044\/intimm_26_9_517.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/intimm\/article-pdf\/26\/9\/517\/45033044\/intimm_26_9_517.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T04:24:01Z","timestamp":1689308641000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/intimm\/article\/26\/9\/517\/2950826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,9]]},"references-count":137,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,6,9]]},"published-print":{"date-parts":[[2014,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/intimm\/dxu063","relation":{},"ISSN":["1460-2377","0953-8178"],"issn-type":[{"value":"1460-2377","type":"electronic"},{"value":"0953-8178","type":"print"}],"subject":[],"published-other":{"date-parts":[[2014,9]]},"published":{"date-parts":[[2014,6,9]]}}}